10.1093/ajcn/88.4.886 18
After starting, dose is adjusted every four weeks, blood sugar is monitored, and any emerging weight loss injection side effects are managed proactively
"There are tons of side effects that go on with this medication, and people are actually sacrificing quite a bit to have thinness and live in a smaller body." Ozempic, Mounjaro and similar medications cannot be given to patients with certain medical conditions, including medullary thyroid cancer, pancreatitis or gallstones
While the new guidance could open the door for broader coverage of GLP-1s that secure additional indications, it would not extend Part D coverage to these therapies to address obesity on its own, according to the article
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity) work through multiple mechanisms to control blood glucose and reduce appetite
GLP-1 (Semaglutide): Reduces appetite Slows gastric emptying Increases satiety Supports sustainable calorie reduction Average weight loss: Up to 15% in 68 weeks (NEJM 2021) GLP-1 + GIP (Tirzepatide): GLP-1 + GIP synergy boosts insulin sensitivity Enhances metabolic balance Further suppresses appetite and cravings Average weight loss: Up to 21% in 72 weeks (SURMOUNT-1) Compounded vs
